Jennifer Urwongse is a seasoned professional with over 16 years of experience in the life science, healthcare, data, and technology sectors. As the Director of Decentralized Clinical Trial Strategy and Innovation at PPD, the clinical research business of Thermo Fisher Scientific, she has been a subject matter expert in decentralized clinical trials (DCT) since 2015. Jennifer specializes in advising on patient-centric strategies to accelerate patient recruitment, as well as increasing patient engagement and retention in Phase I-IV clinical trials. Her extensive expertise extends to providing guidance on both standard and novel decentralized solutions, contributing to the advancement of clinical research methodologies.